StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note released on Tuesday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

Ampio Pharmaceuticals stock opened at $0.10 on Tuesday. Ampio Pharmaceuticals has a 52 week low of $0.07 and a 52 week high of $8.30. The business has a 50-day simple moving average of $0.21 and a 200 day simple moving average of $1.08. The stock has a market cap of $114,000.00, a price-to-earnings ratio of -0.01 and a beta of 2.21.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.